Strafella Claudia, Caputo Valerio, Campoli Giulia, Galota Rosaria Maria, Mela Julia, Zampatti Stefania, Minozzi Giulietta, Sancricca Cristina, Servidei Serenella, Giardina Emiliano, Cascella Raffaella
Genomic Medicine Laboratory UILDM, Santa Lucia Foundation, 00179 Rome, Italy.
Department of Biomedicine and Prevention, Tor Vergata University, 00133 Rome, Italy.
High Throughput. 2020 May 10;9(2):13. doi: 10.3390/ht9020013.
Genetic counseling applied to limb-girdle muscular dystrophies (LGMDs) can be very challenging due to their clinical and genetic heterogeneity and the availability of different molecular assays. Genetic counseling should therefore be addressed to select the most suitable approach to increase the diagnostic rate and provide an accurate estimation of recurrence risk. This is particularly true for families with a positive history for recessive LGMD, in which the presence of a known pathogenetic mutation segregating within the family may not be enough to exclude the risk of having affected children without exploring the genetic background of phenotypically unaffected partners. In this work, we presented a family with a positive history for LGMD2A (OMIM #253600, also known as calpainopathy) characterized by compound heterozygosity for two mutations. The genetic specialist suggested the segregation analysis of both mutations within the family as a first-level analysis. Sequentially, next-generation sequencing (NGS) analysis was performed in the partners of healthy carriers to provide an accurate recurrence/reproductive risk estimation considering the genetic background of the couple. Finally, this work highlighted the importance of providing a genetic counseling/testing service even in unaffected individuals with a carrier partner. This approach can support genetic counselors in estimating the reproductive/recurrence risk and eventually, suggesting prenatal testing, early diagnosis or other medical surveillance strategies.
由于肢带型肌营养不良症(LGMDs)具有临床和遗传异质性以及不同分子检测方法的可用性,因此对其进行遗传咨询可能极具挑战性。因此,应进行遗传咨询以选择最合适的方法,提高诊断率并准确估计复发风险。对于隐性LGMD家族史阳性的家庭来说尤其如此,在这类家庭中,如果不探究表型正常的伴侣的遗传背景,家族中存在已知的致病突变可能不足以排除生育患病子女的风险。在这项研究中,我们展示了一个LGMD2A(OMIM #253600,也称为钙蛋白酶病)家族史阳性的家庭,该家庭具有两个突变的复合杂合性。遗传专家建议将家族中两个突变的分离分析作为一级分析。随后,对健康携带者的伴侣进行了二代测序(NGS)分析,以根据夫妻双方的遗传背景准确估计复发/生殖风险。最后,这项研究强调了即使在有携带者伴侣的未患病个体中提供遗传咨询/检测服务的重要性。这种方法可以帮助遗传咨询师估计生殖/复发风险,并最终建议进行产前检测、早期诊断或其他医学监测策略。